ACE and COVID-19: It is worth noting that seven outpatients (33%) but none of inpatients were treated by on angiotensin‐converting enzyme (ACE) inhibitors and that hospitalized patients had significantly more VOC and ACS during their COVID‐19 than non‐hospitalized patients (Table 2).